Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal

This publication has 51 references indexed in Scilit:

• Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression
  Pharmacology Biochemistry and Behavior, 2007
• Antidepressant-Like Effects of the Corticotropin-Releasing Factor 1 Receptor Antagonist, SSR125543, and the Vasopressin 1b Receptor Antagonist, SSR149415, in a DRL-72 s Schedule in the Rat
  Neuropsychopharmacology, 2006
• Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
  Journal of Clinical Investigation, 2005
• Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test
  Neuroscience & Biobehavioral Reviews, 2005
• Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039
  Biochemical and Biophysical Research Communications, 2004
• Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
  Science, 2003
• Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene
  Science, 2003
• Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• The Hypothalamic-Pituitary-Adrenal System in Depression
  Pharmacopsychiatry, 1998
• Chronic mild stress-induced anhedonia: A realistic animal model of depression
  Neuroscience & Biobehavioral Reviews, 1992